‘Critical role’ of GLP-1s addressed in Australian-first obesity consensus The clinical statement offers GPs guidance on obesity and CVD, recognising GLP-1s have ‘changed the landscape’ as PBS negotiations come under scrutiny.
RSV immunisation program halves newborn hospitalisations Early research shows a ‘phenomenal’ shift in admissions – a turnaround one expert says underscores GPs’ role in patients’ vaccination understanding.
Hantavirus travellers return: What GPs should know Six passengers are now quarantining in Australia – what does this mean for GPs and what should they do to prepare?
Rapid results and long-term gain: The benefits of PoCT A study found the benefits of on-the-spot tests last beyond the consulting room, resulting in longer-term gains for patients.
Frailty experts call for annual screening for over-65s The advice is part of a new framework for consistent care, but one GP expert says doctors must be armed with the ‘means to respond’.
PCOS officially renamed polyendocrine metabolic ovarian syndrome PMOS for short, GPs say the landmark change not only lays to rest a medical misnomer, but will ‘empower’ their diagnoses.
What can GPs do to reform asthma management? A near 40-year stagnation in management of the disease, and system-wide complacency, is costing lives, experts say.
What’s ahead for GPs this flu season? Experts say while it’s a ‘wait and watch’ situation for predominant viruses and severity, GPs remain ‘critical’ to improving vaccine uptake rates.
‘Critical’ role of GPs in new laparotomy clinical standard It aims to enhance care for the 15,000 patients each year who undergo the high-risk surgery, which often entails a lengthy recovery.
Colorectal cancer drug gets PBS listing Fruquintinib (sold as Fruzaqla) will be listed for the first time for the treatment of stage 4 or metastatic colorectal cancer.